Phlexglobal reveals PhlexEview v3
Phlexglobal
has announced the imminent launch of PhlexEview version 3, the third generation of its electronic Trial Master File (eTMF) solution.
PhlexEview 3 features an enhanced client-interface platform, system integration and the option of a “software as a service” model in response to Phlexglobal’s client requests and regulatory recommendations. It also features, as its standard TMF structure, the new DIA TMF Reference Model version 1.1, which was launched on February 9, 2011.
Phlexglobal’s eTMF solution, PhlexEview 3, is a quality-controlled, end-to-end process enabling electronic searching and viewing of centralized TMF documentation from sponsors, subsidiaries, CROs and field-based personnel from anywhere in the world at any time. Whether clients submit paper documents or upload electronic documents, use of PhlexEview 3 will ensure a regulatory compliant eTMF system can be presented to regulators and auditors.
Additions to PhlexEview 3 include new data import and export facilities, improved site architecture, and web services connectors to allow for seamless integration of defined documents with systems such as SharePoint and Documentum. This integration allows for centralized eTMFs without overloading enterprise-wide document management systems.
Other enhancements include features that support clinical trial management such as document comparison options and multiple quality control workflows. An expanded reporting module will be included for the first scheduled client implementations at the end of March 2011. These reports will allow for improved vendor and team oversight.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
